# Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)

> **NCT01462370** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 139 (actual)

## Conditions studied

- Dysmenorrhea

## Interventions

- **DRUG:** Etoricoxib
- **DRUG:** Ibuprofen
- **DRUG:** Placebo to etoricoxib
- **DRUG:** Placebo to ibuprofen
- **DRUG:** Acetaminophen 250 mg, isopropylantipyrine 150 mg and anhydrous caffeine 50 mg

## Key facts

- **NCT ID:** NCT01462370
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01462370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01462370, "Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01462370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*